Intimacy · Reference
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
This page is general information, not legal advice. The List is revised every year and the athlete carries the duty to check.

Treatments mentioned
PT-141, whose drug name is bremelanotide, is not named on the 2026 World Anti-Doping Agency Prohibited List, and neither is oxytocin, the second ingredient in Pepti's PT-141 + Oxytocin vial. That is a different position from kisspeptin, another libido-related peptide, which the List names under S2.2.1 as prohibited in males at all times. Not being named is not the same as being cleared, so a tested athlete should still check their own sport's current rules and keep a record that they did. A standard workplace drug screen does not look for PT-141.
This page is general information, not legal advice. The List is revised every year and the athlete carries the duty to check.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
The short answer
| The question | The answer | Who it affects |
|---|---|---|
| Is PT-141 named on the WADA Prohibited List? | No. Bremelanotide is not named on the 2026 List | Anyone under the World Anti-Doping Code |
| Is oxytocin named? | No | Users of PT-141 + Oxytocin |
| Are other libido peptides named? | Yes. Kisspeptin is named under S2.2.1, prohibited in males | Anyone comparing options |
| Does "not named" mean permitted? | Not automatically. Check your sport's current rules | Every tested athlete |
| Will it show up on a work drug test? | No. Employment panels screen for drugs of abuse only | Employees and job applicants |
| Is it FDA approved? | Bremelanotide is the active ingredient of an FDA-approved drug; the compounded vial is not FDA approved | Anyone reading a sales page |
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
What PT-141 is
PT-141 is bremelanotide, a melanocortin receptor agonist and a metabolite of Melanotan II, developed for sexual desire. It acts on the brain's melanocortin system rather than on blood flow. Two phase 3 randomised trials in 1,267 premenopausal women with acquired, generalised hypoactive sexual desire disorder, published in Obstetrics & Gynecology in 2019, supported an FDA-approved drug with the same active ingredient, approved on 21 June 2019. More is in what is PT-141.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
What the WADA list says
The Prohibited List is published every year and comes into force on 1 January. The 2026 List does not name bremelanotide, oxytocin or Melanotan II. It does name kisspeptin and its agonist analogues under S2.2.1, testosterone-stimulating peptides prohibited in males, and MOTS-c under S4.4.1 as an AMPK activator.
That contrast matters for anyone choosing between libido options, because the products in this category do not share one anti-doping position.
| Product | Named on the 2026 List? | Price |
|---|---|---|
| PT-141 | Bremelanotide is not named | $259/mo |
| PT-141 + Oxytocin | Neither bremelanotide nor oxytocin is named | $259/mo |
| Kisspeptin | Named under S2.2.1, prohibited in males at all times | $229/mo |
| EUPHORIA Blend | Contains kisspeptin-10 (S2.2.1) and MOTS-c (S4.4.1), plus BPC-157 (S0) | $279/mo |
Prices are all-in monthly figures covering medication, physician review, refill management and shipping, with no membership fee. Compounded medications are not FDA approved. The direct comparison is in kisspeptin vs PT-141.
Why "not named" is not the same as "cleared"
The List has a catch-all class, S0, covering any pharmacological substance not addressed by another section "and with no current approval by any governmental regulatory health authority for human therapeutic use." WADA's own explanatory note warns that a substance not specifically named "may still be prohibited." S0 is written around the absence of approval; bremelanotide is the active ingredient of an FDA-approved product. How that applies to a compounded vial in your sport is for your anti-doping body to answer, not a web page.
Sports outside the Code also matter. Professional leagues, military services and some employers run their own policies, and they need not match the WADA List.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
Why a prescription is not the deciding factor
Anti-doping rules operate independently of prescribing law. Article 2.1.1 of the World Anti-Doping Code makes it each athlete's personal duty to ensure that no prohibited substance enters their body, and says intent, fault, negligence or knowing use need not be shown to establish a violation. That is strict liability.
For PT-141 the practical point is not the molecule, which is unnamed, but certainty about what is in the vial. A product bought "for research use only" carries no accountability for identity or purity, and a vial contaminated with or substituted by a named substance is the athlete's problem under strict liability. A prescription filled by a licensed pharmacy with published lot testing is the version where you know what you took.
If your anti-doping body tells you a product is prohibited for you, a therapeutic use exemption granted in advance is the only route to permitted use. In the United States, USADA directs athletes outside its testing pools to its TUE Pre-Check Form, with a stated response time of three to five business days.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
The NCAA
College athletes are governed by the NCAA's banned drug classes rather than the WADA List. One class is "peptide hormones, growth factors, related substances and mimetics," and the NCAA states that any substance chemically or pharmacologically related to a banned class is also banned even if not named, with the school and the student-athlete both accountable. Bremelanotide is not among the NCAA's published examples. Route the question through your athletics health care provider before starting.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
Will PT-141 show up on a drug test?
| Type of test | Does it look for PT-141? | What to do |
|---|---|---|
| Standard workplace panel | No. The federal panel in 49 CFR 40.85 covers drugs of abuse only | Declare prescriptions through the confidential route if asked |
| Expanded workplace panel | No. Expanded panels add more drugs of abuse, not therapeutic classes | Ask what your panel covers |
| Anti-doping test | Bremelanotide is not a named prohibited substance on the 2026 List | Check your sport's current rules and keep the record |
| Clinical testing before a procedure | A safety question, not a screen | Tell the treating clinician; bremelanotide causes a transient blood-pressure rise after each dose |
The wider comparison of the two testing systems is in do peptides show up on a drug test.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
Where PT-141 stands with the FDA
Because bremelanotide is a component of an FDA-approved product, it may be used in 503A compounding without depending on the bulks list, and it was never in Category 2. A compounded PT-141 vial is a different formulation, prepared by a licensed pharmacy to an individual prescription; it has not been reviewed by the FDA and is not FDA approved. Prescribing it after menopause, or to men, is off-label use of an approved active. More is in PT-141 benefits and PT-141 side effects.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
If you compete: what to do
| Your situation | What applies |
|---|---|
| In a tested pool, considering PT-141 | Check your sport's current rules and Global DRO before starting, and keep the reference number |
| Comparing PT-141 with kisspeptin | Kisspeptin is named under S2.2.1 for males; bremelanotide is not |
| Considering EUPHORIA | It contains three named substances; not an option for a tested athlete |
| A college athlete | Ask your athletics health care provider first |
| Considering a research-labelled vial | Do not. Contents are unverified, a strict-liability problem; see research peptides vs prescription peptides |
Who should not take PT-141, or should discuss it first, is a medical question rather than a sport one: anyone with uncontrolled high blood pressure or heart disease, anyone taking oral naltrexone, anyone with a history of melanoma or atypical moles, and anyone pregnant or breastfeeding, where it is not used.
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests
Where to get PT-141 prescribed
PT-141 cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with. If you are subject to anti-doping testing, say so there.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a state-licensed, FDA-registered US pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial, with sterile syringes and alcohol prep pads.
- Your physician stays reachable for questions through your account.
Step-by-step page: how to get PT-141 prescribed online. Dosing detail is in PT-141 dosage.
References
What this is based on.
References
- Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH. Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder · Obstetrics & Gynecology (2019) · PMID 31599847
- Clayton AH, Althof SE, Kingsberg S, DeRogatis LR, Kroll R, Goldstein I, Kaminetsky J, Spana C, Lucas J, Jordan R, Portman DJ. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial · Women's Health (London) (2016) · PMID 27181790
- Clayton AH, Kingsberg SA, Portman D, Sadiq A, Krop J, Jordan R, Lucas J, Simon JA. Safety Profile of Bremelanotide Across the Clinical Development Program · Journal of Women's Health (2022) · PMID 35147466
- Pfaus JG, Sadiq A, Spana C, Clayton AH. The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women · CNS Spectrums (2022) · PMID 33455598
- Diamond LE, Earle DC, Rosen RC, Willett MS, Molinoff PB. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction · International Journal of Impotence Research (2004) · PMID 14963471
- Rosen RC, Diamond LE, Earle DC, Shadiack AM, Molinoff PB. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra · International Journal of Impotence Research (2004) · PMID 14999221
- Diamond LE, Earle DC, Garcia WD, Spana C. Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response · Urology (2005) · PMID 15833522
- Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction · Annals of the New York Academy of Sciences (2003) · PMID 12851303
- Kingsberg SA, Clayton AH, Portman D, et al.. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials · Obstetrics & Gynecology (2019) · PMID 31599840
- Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease · JAMA (2005) · PMID 16414947
- Nehra A, Jackson G, Miner M, Billups KL et al.. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease · Mayo Clin Proc (2012) · PMID 22862865
- Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients · J Clin Endocrinol Metab (2005) · PMID 16204360
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Is PT-141 Banned in Sports? Bremelanotide, WADA and Drug Tests, answered.
Bremelanotide is not named on the 2026 WADA Prohibited List. The List's catch-all wording means a tested athlete should still check their own sport's current rules before starting.
Its human research concerns sexual desire and erectile response, and it acts on the melanocortin system in the brain. Whatever it does or does not do, its status for you turns on your sport's rules, not on how it is marketed.
Yes. The 2026 List names kisspeptin and its agonist analogues under S2.2.1 as testosterone-stimulating peptides prohibited in males at all times. Bremelanotide sits in no named class.
Oxytocin is not named on the 2026 Prohibited List. The same caution applies: check your sport's current rules for the combined vial.
Not on a workplace panel, which screens only for drugs of abuse. On an anti-doping test, bremelanotide is not a named prohibited substance; check your own sport's rules.
It is not among the NCAA's published examples, but the NCAA bans anything chemically or pharmacologically related to a banned class. Ask your athletics health care provider before starting.
Neither is named on the 2026 List. They act on the same receptor family, but they are different molecules with different evidence; see PT-141 vs Melanotan II.
Bremelanotide is the active ingredient of a drug the FDA approved on 21 June 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Compounded PT-141 is a different formulation and is not FDA approved.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.



